| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044936 Administering a monoclonal antibody or fragment thereof which acts as an antagonist of the integrins GPIIb/IIIa ( alpha IIb beta 3) and alpha v beta 3; also treating inflammatory diseases such as rheumatoid arthritis, psoriasis |
| 04/18/2002 | US20020044935 Peptides of IL-2 and derivatives thereof and their use as therapeutic agents |
| 04/18/2002 | US20020044934 Therapies for smoke and/or burn induced lung injury |
| 04/18/2002 | US20020044933 Inhibition of intimal hyperplasia using antibodies to PDGF receptors |
| 04/18/2002 | US20020044932 Monocyte chemoattractant activity of galectin-3 |
| 04/18/2002 | US20020044930 Severe combined immunodeficiency disease (SCID); immunotherapy of human diseases such as prostate cancer |
| 04/18/2002 | US20020044922 Recombinant phages |
| 04/18/2002 | DE10021678A1 Recombinant polyspecific antibody constructs, useful for diagnosis and treatment of cancer, comprises three antibody fragments,where at least one comprises a disulfide bridge |
| 04/18/2002 | CA2785941A1 Antibody composition-producing cell |
| 04/18/2002 | CA2425818A1 Novel human beta2 integrin alpha subunit |
| 04/18/2002 | CA2425809A1 Humanized anti-lt-.beta.-r antibodies |
| 04/18/2002 | CA2425767A1 Lipocalins |
| 04/18/2002 | CA2425689A1 Method for modifying a protein structure |
| 04/18/2002 | CA2425643A1 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | CA2425410A1 Evaluating binding affinities by force stratification and force panning |
| 04/18/2002 | CA2425356A1 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | CA2425318A1 Far red shifted fluorescent proteins |
| 04/18/2002 | CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | CA2425001A1 Novel serine protease genes related to dppiv |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424946A1 Non typeable haemophilus influenzae basb201 polypeptides and encoding polynucleotides and uses thereof |
| 04/18/2002 | CA2424933A1 Haemophilus influenza basb203 polypeptides and encoding polynucleotides and uses thereof |
| 04/18/2002 | CA2424821A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | CA2424379A1 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 04/18/2002 | CA2423850A1 Therapeutic antibodies |
| 04/18/2002 | CA2422881A1 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197225A1 REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP |
| 04/17/2002 | EP1197224A1 Agents for ameliorating low vasopressin level |
| 04/17/2002 | EP1196782A1 Catalytic anti-factor viii allo-antibodies |
| 04/17/2002 | EP1196779A1 Determining antibodies to ny-eso-1 in cancer patients |
| 04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196600A1 Drosophila recombination-associated protein and methods for use |
| 04/17/2002 | EP1196598A1 Dsp-3 dual-specificity phosphatase |
| 04/17/2002 | EP1196597A2 Linoleate isomerase |
| 04/17/2002 | EP1196587A2 Antigenic meningococcal peptides |
| 04/17/2002 | EP1196586A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 04/17/2002 | EP1196584A1 Tetanus toxin polypeptides |
| 04/17/2002 | EP1196578A1 Axor39, a g-protein coupled receptor with 7-tm segments |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196570A2 Human polypeptides and methods for the use thereof |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196566A1 Expression vectors and methods |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196562A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 04/17/2002 | EP1196561A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196543A2 Treatment of dendritic cells for induction of immune tolerance |
| 04/17/2002 | EP1196437A1 Fima PILUS-BASED VACCINES |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196031A1 Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells |
| 04/17/2002 | EP1125107A4 Tests for the rapid evaluation of ischemic states and kits |
| 04/17/2002 | EP0852627A4 Cell death protein |
| 04/17/2002 | EP0793506B1 Cellular and serum protein anchors and conjugates |
| 04/17/2002 | EP0707485B1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/17/2002 | EP0500785B1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 04/17/2002 | CN1345375A Streptococcus pneumoniae antigens |
| 04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 04/17/2002 | CN1345334A Antibodies specific to KDR and uses thereof |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/17/2002 | CN1344800A New polypeptide human phosphoglycerol diesterase 31.56 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344798A New polypeptide human dioxygenase 10.12 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344746A Prepn and application of individual antitumor specific antibody |
| 04/17/2002 | CN1344744A Human testicular development specific protein-27 gene encoding protein |
| 04/17/2002 | CN1344743A Human testicular development specific protein-26 gene encoding protein |
| 04/17/2002 | CN1344742A Human testicualr development specific protein-24 gene encoding protein |
| 04/17/2002 | CN1344741A Human testicular development specific protein-21 gene encoding protein |
| 04/17/2002 | CN1344740A Human testicular development specific protein-20 gene encoding protein |
| 04/17/2002 | CN1344739A Human testicular development specific protein-20B gene encoding protein |
| 04/17/2002 | CN1344738A Human testicular development specific protein-18 gene encoding protein |
| 04/17/2002 | CN1344737A Human testicular development specific protein-5 gene encoding protein |
| 04/17/2002 | CN1344736A 9-0-acetyl esterase gene encoding protein |
| 04/17/2002 | CN1344735A Human testicular development specific protein-19 gene encoding protein |
| 04/17/2002 | CN1344734A New polypeptide huamn autosomal fragile mental retardation syndrome related protein 10.45 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344733A New polypeptide human transcription factor LCR-F15.95 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344732A New polypeptide human zinc finger protein 10.12 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344731A New polypeptide human excitatory amino acid translocator 12.65 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344730A New polypeptide human ribosomal protein S9.9 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344729A New polypeptide human visinin-like protein 13.75 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344728A New polypeptide human macro protein 0193-20.79 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344726A New polypeptie ribosomal protein S15.84 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344725A New polypeptide protein 86.90 with rich proline and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344724A New polypeptide mitochondrion sorting protein 1-39.71 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1082821C Antibody cojugates |
| 04/16/2002 | US6372900 Horse endothelin-B receptor gene and gene products |
| 04/16/2002 | US6372899 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 04/16/2002 | US6372891 Human G-protein receptor HPRAJ70 |
| 04/16/2002 | US6372890 Water-soluble polypeptides |
| 04/16/2002 | US6372886 Useful for expression of the kringle domains and to the production of antibodies to human lipoprotein |
| 04/16/2002 | US6372884 Comparing amino acid sequences of complementarity-determining regions of an anti-receptor antibody that mimics or blocks a biologically active protein; identifying amino acid sequence in complementarity-determining region; synthesizing |